Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice

Peptides

Volumn 30, Issue 7, 2009, Pages 1313-1317

  Han, Ren Wen ^a   Chang, Min ^a   Peng, Ya Li ^a   Qiao, Lian yong ^a   Yin, Xin Qiang ^a   Li, Wei ^a   Wang, Rui ^a,b  

^a Institute of Biochemistry and Molecular Biology   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Bead expulsion; Distal colonic transit; Fecal pellet output; Neuropeptide S (NPS); Neuropeptide S receptor (NPSR)

Indexed keywords

NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISTAL COLON TRANSIT; DRUG TARGETING; GASTROINTESTINAL TRANSIT; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; COLON; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED;

MUS;

EID: 67249128081     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.03.012     Document Type: Article

References (41)

1. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., and Kasuga M. Motilin increases food intake in mice. Peptides 19 (1998) 987-990
2. Badia-Elder N.E., Henderson A.N., Bertholomey M.L., Dodge N.C., and Stewart R.B. The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats. Alcohol Clin Exp Res 32 (2008) 1380-1387
3. Baynes K.C., Dhillo W.S., and Bloom S.R. Regulation of food intake by gastrointestinal hormones. Curr Opin Gastroenterol 22 (2006) 626-631
4. Beck B., Fernette B., and Stricker-Krongrad A. Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochem Biophys Res Commun 332 (2005) 859-865
5. Benarroch E.E. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc 68 (1993) 988-1001
6. Bernier V., Stocco R., Bogusky M.J., Joyce J.G., Parachoniak C., Grenier K., et al. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem 281 (2006) 24704-24712
7. Calo G., Guerrini R., Rizzi A., Salvadori S., and Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br J Pharmacol 129 (2000) 1261-1283
8. Camarda V., Rizzi A., Ruzza C., Zucchini S., Marzola G., Marzola E., et al. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. J Pharmacol Exp Ther 328 (2009) 549-555
9. Castro A.A., Moretti M., Casagrande T.S., Martinello C., Petronilho F., Steckert A.V., et al. Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacol Biochem Behav (2008)
10. Chen J.J., Li Z., Pan H., Murphy D.L., Tamir H., Koepsell H., et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci 21 (2001) 6348-6361
11. Cline M.A., Godlove D.C., Nandar W., Bowden C.N., and Prall B.C. Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus). Comp Biochem Physiol A Mol Integr Physiol 148 (2007) 657-663
12. Cline M.A., Prall B.C., Smith M.L., Calchary W.A., and Siegel P.B. Differential appetite-related responses to central neuropeptide S in lines of chickens divergently selected for low or high body weight. J Neuroendocrinol 20 (2008) 904-908
13. D'Amato M., Bruce S., Bresso F., Zucchelli M., Ezer S., Pulkkinen V., et al. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 133 (2007) 808-817
14. De Vriese C., and Delporte C. Ghrelin: a new peptide regulating growth hormone release and food intake. Int J Biochem Cell Biol 40 (2008) 1420-1424
15. Guerrini R., Camarda V., Trapella C., Calo G., Rizzi A., Ruzza C., et al. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists. J Med Chem 52 (2009) 524-529
16. Ishiguchi T., Itoh H., and Ichinose M. Gastrointestinal motility and the brain-gut axis. Dig Endosc 15 (2003) 81-86
17. Jungling K., Seidenbecher T., Sosulina L., Lesting J., Sangha S., Clark S.D., et al. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 59 (2008) 298-310
18. Kaga T., Fujimiya M., and Inui A. Emerging functions of neuropeptide Y Y(2) receptors in the brain. Peptides 22 (2001) 501-506
19. Konturek S.J., Konturek J.W., Pawlik T., and Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55 (2004) 137-154
20. Lage R., Dieguez C., and Lopez M. Caffeine treatment regulates neuropeptide S system expression in the rat brain. Neurosci Lett 410 (2006) 47-51
21. Lage R., Gonzalez C.R., Dieguez C., and Lopez M. Nicotine treatment regulates neuropeptide S system expression in the rat brain. Neurotoxicology 28 (2007) 1129-1135
22. Li W., Gao Y.H., Chang M., Peng Y.L., Yao J., Han R.W., et al. Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice. Peptides 30 (2009) 234-240
23. Meis S., Bergado-Acosta J.R., Yanagawa Y., Obata K., Stork O., and Munsch T. Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS ONE 3 (2008) e2695
24. Million M., Wang L., Martinez V., and Tache Y. Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in Fischer and Lewis rats. Brain Res 877 (2000) 345-353
25. Mondal M.S., Nakazato M., and Matsukura S. Orexins (hypocretins): novel hypothalamic peptides with divergent functions. Biochem Cell Biol 78 (2000) 299-305
26. Niimi M. Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats. Endocrine 30 (2006) 75-79
27. Okamura N., Habay S.A., Zeng J., Chamberlin A.R., and Reinscheid R.K. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J Pharmacol Exp Ther 325 (2008) 893-901
28. Osinski M.A., Bass P., and Gaumnitz E.A. Peripheral and central actions of orphanin FQ (nociceptin) on murine colon. Am J Physiol 276 (1999) G125-G131
29. Peikin S.R. Role of cholecystokinin in the control of food intake. Gastroenterol Clin North Am 18 (1989) 757-775
30. Peng Y.L., Chang M., Dong S.L., Li W., Han R.W., Fu G.X., et al. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor. Regul Pept 134 (2006) 75-81
31. Pulkkinen V., Majuri M.L., Wang G., Holopainen P., Obase Y., Vendelin J., et al. Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. Hum Mol Genet 15 (2006) 1667-1679
32. Reinscheid R.K., Xu Y.L., Okamura N., Zeng J., Chung S., Pai R., et al. Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315 (2005) 1338-1345
33. Rizzi A., Vergura R., Marzola G., Ruzza C., Guerrini R., Salvadori S., et al. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 154 (2008) 471-479
34. Roth A.L., Marzola E., Rizzi A., Arduin M., Trapella C., Corti C., et al. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J Biol Chem 281 (2006) 20809-20816
35. Smith K.L., Patterson M., Dhillo W.S., Patel S.R., Semjonous N.M., Gardiner J.V., et al. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 147 (2006) 3510-3518
36. Vendelin J., Pulkkinen V., Rehn M., Pirskanen A., Raisanen-Sokolowski A., Laitinen A., et al. Characterization of GPRA, a novel G protein-coupled receptor related to asthma. Am J Respir Cell Mol Biol 33 (2005) 262-270
37. Vitale G., Filaferro M., Ruggieri V., Pennella S., Frigeri C., Rizzi A., et al. Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides 29 (2008) 2286-2291
38. Xing J., and Chen J.D. Alterations of gastrointestinal motility in obesity. Obes Res 12 (2004) 1723-1732
39. Xu Y.L., Gall C.M., Jackson V.R., Civelli O., and Reinscheid R.K. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500 (2007) 84-102
40. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497
41. Zhang Y., Gilmour B.P., Navarro H.A., and Runyon S.P. Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for Neuropeptide S antagonist activity. Bioorg Med Chem Lett 18 (2008) 4064-4067